Global Market

>
Global Market
Global Market
Kelun has actively implemented the international strategy. Its leading products have achieved batch exports, enjoying a good reputation in over 50 countries and territories.  Kelun`s cooperation with the Korea Doosan Group (Fortune Global 500) to produce medicinal lecithin has filled a domestic gap in this field. Kelun-Kazpharm was established in Kazakhstan and put into production in 2014, answering the call of the national strategy for “The New Silk Road Economic Belt”. This project has been incorporated into the “Kazakhstan Industrial Development Support Plan” and “2050 Development Strategy”. Furthermore, the project “Key Generic IV Solution Technology Research and Industrialized Demonstration” undertaken by Kazakhstan Kelun was approved by the Ministry of Science and Technology of the People`s Republic of China (MOST) in 2014, as a science and technology assistance project for developing countries. Kelun, with a focus on Kelun-Kazpharm, has extended to Central Asia and other former CIS countries, which marked a solid step in foreign direct investment. In 2018, Sichuan Kelun Pharmaceutical Co., Ltd. acquired the GMP Compliance Inspection Result Notification of PMDA (Japanese Pharmaceuticals and Medical Devices Agency) and became the first Chinese-funded IV solution manufacturer that passed Japan PMDA GMP inspection in China.